Tethered Capsule Endomicroscopy for Barrett's Esophagus
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new screening method for Barrett's esophagus, a condition where the esophageal lining changes and may lead to cancer. The test uses a small capsule on a string to capture images inside the esophagus, potentially making early detection easier and more comfortable in primary care settings. The study seeks participants who are patients at specific primary care practices and have fasted for at least one hour before the procedure. This trial aims to determine the prevalence of Barrett's esophagus in the general population. As an unphased trial, it offers a unique opportunity to contribute to research that could enhance early detection methods for Barrett's esophagus.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that tethered capsule endomicroscopy is safe for screening Barrett's esophagus?
Research has shown that tethered capsule endomicroscopy (TCE) is generally safe and well-tolerated. Studies have demonstrated that patients with Barrett's esophagus, a condition where the lining of the esophagus changes, underwent this procedure without serious issues. In 90% of these cases, high-quality images were captured, indicating effective performance.
The studies found the procedure safe, with participants reporting few side effects. Most people did not experience significant discomfort or problems during the test. Overall, TCE appears to be a promising and safe tool for screening Barrett's esophagus.12345Why are researchers excited about this trial?
Tethered Capsule Endomicroscopy (TCE) is unique because it offers a non-invasive and patient-friendly way to screen for Barrett's Esophagus, a condition that can lead to esophageal cancer. Unlike traditional endoscopy, which can be uncomfortable and requires sedation, TCE involves swallowing a small capsule attached to a thin tether, which captures detailed images of the esophagus as it is gently pulled back up. Researchers are excited about TCE because it has the potential to be used easily in primary care settings, making screening more accessible and widespread. This could lead to earlier detection and treatment, ultimately improving patient outcomes.
What evidence suggests that tethered capsule endomicroscopy is effective for screening Barrett's esophagus?
Research has shown that tethered capsule endomicroscopy (TCE), which participants in this trial will undergo, is a promising method for detecting Barrett's esophagus. Studies have found that it provides clear images of the esophagus in 90% of patients. TCE is less invasive and more comfortable than traditional endoscopy, with no reported side effects. Many patients prefer TCE because it is simpler and painless. This technique has proven safe for people with Barrett's esophagus and other digestive issues. Overall, TCE appears to be an effective and preferred option for detecting Barrett's esophagus.12467
Who Is on the Research Team?
Guillermo Tearney, M.D, PhD.
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for adults aged 18-75 who are patients at the Assembly Row primary care practice, can consent to participate, and haven't eaten for an hour before the procedure. It's not for pregnant individuals, those with swallowing difficulties, urgent symptoms like fever or abdominal pain, a history of certain GI surgeries or Crohn's disease.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Procedure
Participants undergo tethered capsule endomicroscopy to screen for Barrett's esophagus
Follow-up
Participants are monitored for safety and effectiveness after the procedure
What Are the Treatments Tested in This Trial?
Interventions
- Tethered Capsule Endomicroscopy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor